MMP3 and rheumatoid arthritis: This study showed that this effect was not mediated by CB1 and CB2,43 suggesting the involvement of other cannabis-related receptors.43 Another group confirmed the WIN55,212-2 results and further showed that treatment reduced the release of the MMP3 from synovial fibroblasts from RA and OA patients.